-
Chinese (Simplified)
-
English
-
German
-
Korean
-
Spanish
Chinese (Simplified)
English
German
Korean
Spanish
Sign up for an account to enjoy easy online shopping and instant order tracking.
The antibody against IFI35 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-288 of human IFI35 (NP_005524.2) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.
The antibody against IFI35 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-288 of human IFI35 (NP_005524.2) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.
| Cat.No | ADA-08746A | Clonality | Polyclonal |
|---|---|---|---|
| Host Species | Rabbit | Target Name | IFI35 |
| Target Synonyms | IFP35; IFI35 | Form | Liquid |
| Species Reactivity | Human, Mouse | Isotype | IgG |
| Storage Buffer | 50% Glycerol, PBS with 0.01% thimerosal, pH7.3. | Purification Method | Affinity purification |
| Positive Samples | HeLa, A-431, HepG2 | Application | ELISA, WB |
| Immunogen Description | Recombinant fusion protein containing a sequence corresponding to amino acids 1-288 of human IFI35 (NP_005524.2). | Target Species | Human |
|---|---|---|---|
| Uniprot ID | P80217 | Immunogen Sequence |
Uniprot Id
P80217
Target Species
Human
Target Name
IFI35
Target Full Name
Interferon-induced 35 kDa protein
Target Function
Acts as a signaling pathway regulator involved in innate immune system response. In response to interferon IFN-alpha, associates in a complex with signaling pathway regulator NMI to regulate immune response; the complex formation prevents proteasome-mediated degradation of IFI35 and correlates with IFI35 dephosphorylation. In complex with NMI, inhibits virus-triggered type I interferon/IFN-beta production. In complex with NMI, negatively regulates nuclear factor NF-kappa-B signaling by inhibiting the nuclear translocation, activation and transcription of the NF-kappa-B subunit p65/RELA, resulting in the inhibition of endothelial cell proliferation, migration and re-endothelialization of injured arteries. Beside its role as an intracellular signaling pathway regulator, also functions extracellularly as damage-associated molecular patterns (DAMPs) to promote inflammation when actively released by macrophage to the extracellular space during cell injury and pathogen invasion. Macrophage-secreted IFI35 activates NF-kappa-B signaling in adjacent macrophages through Toll-like receptor 4/TLR4 activation, thereby inducing NF-kappa-B translocation from the cytoplasm into the nucleus which promotes the release of proinflammatory cytokines
Target Subcellular Location
Cytoplasm. Nucleus. Secreted.
Target Protein Families
NMI family
Target Tissue Specificity
Expressed in a wide range of cell types, including fibroblasts, macrophages, and epithelial cells.
Target Synonyms
FLJ21753; IFI 35; Ifi-35; Ifi35; IFP 35; IFP35; IN35; IN35_HUMAN; Interferon induced 35 kDa protein; Interferon-induced 35 kDa protein; OTTHUMP00000236626; OTTHUMP00000236627
Notification